Transient receptor potential vanilloid type 1 receptors in hypertensive renal damage: a promising therapeutic target?
Ditting
Tilmann
T
Veelken
Roland
R
Hilgers
Karl F
KF
D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D003900:Desoxycorticosterone / Q000494:pharmacology*; D004195:Disease Models, Animal; D018450:Disease Progression; D016503:Drug Delivery Systems; D005500:Follow-Up Studies; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D007677:Kidney Function Tests; D051379:Mice; D008817:Mice, Mutant Strains; D009400:Nephrosclerosis / Q000209:etiology / Q000517:prevention & control*; D011897:Random Allocation; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D050916:TRPV Cation Channels / Q000187:drug effects / Q000378:metabolism*
D015415:Biomarkers; D050916:TRPV Cation Channels; C494484:TRPV1 receptor; D003900:Desoxycorticosterone